We observed high variation in the number of CD4+ Tem, Teff, and Treg in AML patients, except for CD4+CCR7+Tn and CD4+TCF7+Tcm, which were prevalent in peripheral blood in AML and healthy samples (Fig. 2c, Supplementary Fig. 5b). This evidence concerns the gene CD4 and acute myeloid leukemia.